CPAC

Supreme Court Hearings

Loading video...

Supreme Court Hearings - Theratechnologies inc., et al. v. 121851 Canada inc.


Case # 35550
Theratechnologies inc., et al. v. 121851 Canada inc. (December 1, 2014)

In May 2010 the U.S. Food and Drug Administration published information on its site about new drugs awaiting approval. In the case of Tesamorelin, developed by Theratechnologies, the article referred to some questions and objections raised by the FDA. The information attracted the attention of stock market rating companies like Bloomberg, Dow Jones and Thomson Reuters. The rating companies expressed their reservations at the drug in a press release. Following this the stock dropped precipitously. Subsequently, however, the FDA approved the drug and the stock returned to its previous level. The class action was authorized against the appellant on the basis it failed to disclose questions the FDA had posed about the drug.












more less

Related Videos

Beyond Politics

Justice Beverley McLachli...

Journalist Catherine Clark speaks with Supreme Court Judge Beverley McLachlin

Beyond Politics

Justice Richard Wagner

Journalist Catherine Clark speaks with Supreme Court Judge Richard Wagner

Beyond Politics

Justice Rosalie Abella

Journalist Catherine Clark speaks with Supreme Court Judge Rosalie Abella

Beyond Politics

Justice Clément Gascon

Catherine Clark spoke to Justice Clément Gascon in Ottawa.